期刊文献+

Livin、CD44v6、E-钙黏蛋白在非小细胞肺癌组织中的表达及意义 被引量:1

Expression and clinicopathologic significance of livin, CD44v6 and E-cadherin proteins in non-small cell lung cancer
下载PDF
导出
摘要 目的 检测非小细胞肺癌(NSCLC)癌组织和癌旁组织中Livin、CD44v6、E-钙黏蛋白(E-cad)的表达,探讨NSCLC组织Livin、CD44v6、E-cad表达的临床意义.方法 运用免疫组织化学染色法检测71例NSCLC组织、癌旁组织及20例良性肺组织标本中Livin、CD44v6、E-cad的表达情况,分析其与肺癌分期、分化、病理类型及淋巴结转移之间的关系及相关性.结果 (1)肺癌组织中Livin阳性表达率明显增高,与癌旁组织及良性肺组织比较差异有统计学意义(P<0.01),癌旁组织中Livin阳性表达率较良性肺组织中增高,但差异无统计学意义(P >0.05); Livin在Ⅲ期肺癌中表达较Ⅰ、Ⅱ期明显增高,其表达与肺癌TNM分期呈正相关;淋巴结转移组Livin阳性率86.2%(25/29),高于无淋巴结转移组23.8%(10/42),两组比较差异有统计学意义(P<0.01).(2)CD44v6在肺癌组织中表达增高,与癌旁组织及良性肺组织比较差异有统计学意义(P<0.01); CD44v6表达与临床病理分期(TNM)呈正相关(P<0.01).淋巴结转移组CD44v6阳性率96.6%(28/29),高于无淋巴结转移组[33.3%(14/42)],两组比较差异有统计学意义(P<0.01);CD44v6的表达与肺癌的分化程度呈负相关(P<0.05).(3)E-cad在肺癌组织中表达降低,与癌旁组织及良性肺组织相比差异有统计学意义(P<0.01).E-cad的表达与临床病理分期、淋巴结转移、分化程度无关(均P >0.05).(4)Livin与CD44v6在肺癌组织均有较高表达,Livin阳性表达组中CD44v6的表达强度较阴性组明显增高,Livin与CD44v6表达呈正相关(P<0.01).Livin与E-cad在肺癌组织中的表达无相关性.结论 Livin、CD44v6在NSCLC组织中高表达、E-cad在NSCLC组织中表达降低,Livin、CD44v6与NSCLC临床病理分期、淋巴结转移的相关,提示三者在NSCLC的发病过程中可能起重要作用.CD44v6 与Livin在肺癌组织中的表达呈正相关,推测两者可能共同参与了NSCLC的疾病过程,其确切机制有待于进一步研究. Objective To investigate the expression and clinical significance of livin, CD44v6 and E-cadherin proteins in non-small cell lung cancer (NSCLC ). Methods The expression of livin, CD44v6 and E-cadherin proteins were examined with immunohistochemistry in cancer and precancerous tissue specimens of 71 NSCLC cases and 20 specimens of normal lung tissue. The correlation of protein expressions with clinical stages, pathological types, pathological grades, lymph nodes metastasis was analyzed. Results The expressions of livin and CD44v6 in cancer tissue were significantly higher than those in pericancerous and normal lung tissues(P〈0.01 ). The expressions of livin and CD44v6 in cancer tissue of NSCLC were positively correlated with PTNM and lymph node metastasis (P〈0.01 ). The over-expression of CD44v6 was also positively correlated with pathological grades of NSCLC (P〈0.05 ). There was a positive corrlrtions between expression of livin with CD44v6 (P〈0.01 ). The expression of E-cadherin in NSCLC was significantly lower than that in pericancerous and normal tissues. The expression of E-cadherin had no relationships with clinical stages, pathological grades, pathological types and metastatic states of lymph node in NSCLC. Conclusion The expressions of livin, CD44v6 and E-cadherin proteins are related to the biological behavior and prognosis of NSCLC, which might be useful biological markers for NSCLC.
出处 《浙江医学》 CAS 2011年第12期1743-1745,1752,I0017,共5页 Zhejiang Medical Journal
关键词 非小细胞肺癌 CD44V6 LIVIN E-钙黏蛋白 免疫组织化学 Non-small cell lung cancer CD44v6 Livin E-cadherin Immunohistochemistry
  • 相关文献

参考文献7

  • 1Ka H,Hunt J.Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas[J].Am J pathol,2003,163(2)∶413-422.
  • 2Crnkovi(c)-Mertens I,Muley T,Meister M,et al.The anti-apoptotic livin gene is an important determinant for the apoptotic resistance of non-small cell lung cancer cells[J].Lung Cancer,2006,54(2)∶135-142.
  • 3Yuan D,Liu L,Xu H,et al.The effects on cell growth and chem-osensitivity by livin RNAi in non-small cell lung cancer[J].Mol Cell Biochem,2009,320(1-2)∶133-140.
  • 4Guan YY,Miao LY,Sun JJ.Effects of Rb1 fromthe panax notogmseng saponins on arrbthmia and the Ca2+movement in rat heart cells.Drug Development,1996,39:179-183.
  • 5Afify A M,Tate S,Durbin-Johnson B,et al.Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors[J].Int J Biol Markers,2011,26(1)∶50-57.
  • 6Liu Y,Wang Y,Zhang Y,et al.Abnormal expression of p120-catenin,E-cadherin,and small GTPases is significantly associated with malignant phenotype of human lung cancer[J].Lung Cancer,2009,63(3)∶375-382.
  • 7陈淼,陶晓南,张晓菊.凋亡抑制蛋白livin在非小细胞肺癌中的表达及临床意义[J].广东医学,2006,27(7):1014-1015. 被引量:5

二级参考文献5

  • 1孙建国,廖荣霞,陈正堂,王志新,张青,伍伟玲.一种新的凋亡抑制蛋白Livin在非小细胞肺癌组织中的表达[J].重庆医学,2004,33(7):982-984. 被引量:47
  • 2KASOF G M,GOMES B C.Livin,a novel inhibitor of apoptosis protein family member[J].J Biol Chem,2001,276:3238-3246.
  • 3VACIC D,STENNICKEIF,PISABARROMT,etal.Ml-IAP,anovel inhibitor that is preferentially expressed in human nelanomas[J].Curr Biol,2000,10(2):1359-1366.
  • 4HOFMANN H S,SIMM A,HAMMER A.et al.Expression of insitors of apoptosis (IAP) proteins in non-small cell human lung cancer[J].J Caucer Res Clin Oncol,2002,128(10):554-560.
  • 5张华东,袁守军,陈惠鹏.Livin——癌症治疗的新靶点[J].中国药理学通报,2003,19(8):845-847. 被引量:13

共引文献5

同被引文献8

  • 1RTOG. RTOG/EORTC放射损伤分级标//殷蔚伯,谷铣之.肿瘤放射治疗学[M]. 4版.北京:中国协和医科大学出版社,2008 :1108-1111.
  • 2陆舜.肺癌的发病和预后//钱浩.肺癌综合治疗[M].南京r江苏科学技术出版社,2008:99-104.
  • 3Joo M, Lee HK, Kang YK. Expression of E-cadherin, p-catenin,CD44s and CD44v6 in gastric adenocarcinoma:relationship with lymphnode metastasis[ J]. Anticancer Res,2003 ,23(26): 1581-1588.
  • 4Marhaba R, Zoller M. CD44 in cancer progression : adhension, migra-tion and growth regulation[ J]. J Mol Histol,2004 ,35(3):211-231.
  • 5Ponta H, Sheman L,Herrlich PA. CD44 :from adhesion molecules tosignaling regulators[ J]. Nat Rev Mol Cell Biol,2003 ,4(1):33-45.
  • 6Arkadiusz ZD, Hemchandra M. circulating angiogenic cytokines inpatients with advanced non-small cell lung cancer: correlation withtreatment response and survival [ J ]. Cancer Investigation,2005,23(2):193-200.
  • 7易明福,魏晓梅.E-cad、CD_(44)v6基因表达与非小细胞肺癌淋巴转移的关系[J].临床肺科杂志,2010,15(2):157-158. 被引量:9
  • 8宋平平,张百江,张为迪,董印军,刘希斌.非小细胞肺癌组织CD44V6和CK19表达及其与临床病理特征的关系[J].中华肿瘤防治杂志,2010,17(22):1821-1823. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部